These predictions are conditionally blended and heuristically used [17], such as to produce estimates of the lowest predicted glucose value to be observed over the timeframe relevant for insulin dosing and separately the blended average glucose level over the approximate period when the activity of any additional insulin would be peaking, in order to limit contributions to hypoglycemia while also seeking to minimize hyperglycemia. The gene discussed is INS; the disease is Hypoglycemia.